Aristo Bio-Tech And Lifescience Profile
Key Indicators
- Authorised Capital ₹ 8.00 Cr
- Paid Up Capital ₹ 6.81 Cr
- Company Age 19 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 57.60 Cr
- Satisfied Charges ₹ 9.61 Cr
About Aristo Bio-Tech And Lifescience
Aristo Bio-Tech And Lifescience Limited (ABALL) is a leading Public Limited Indian Non-Government Company incorporated in India on 17 March 2005 and has a history of 19 years and 11 months. Its registered office is in Vadodara, Gujarat, India.
The Corporate was formerly known as Aristo Bio-Tech And Lifescience Private Limited. The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 Cr and a paid-up capital of Rs 6.81 Cr.
The company currently has active open charges totaling ₹57.60 Cr. The company has closed loans amounting to ₹9.61 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Aristo Bio-Tech And Lifescience Limited India are Ketankumar Joshi as CFO and Chinmay Chokshi as Company Secretary. Kusum Barhat, Ketankumar Joshi, Raghavender Mateti, and Three other members serve as directors at the Company.
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U01100GJ2005PLC127397
- Company No.
152037
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Mar 2005
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
What products or services does Aristo Bio-Tech And Lifescience Limited offer?
Aristo Bio-Tech And Lifescience Limited offers a wide range of products and services, including Insecticides and Pesticides, Fungicides, Termiticide, Bispyribac Sodium, Ziram, Imidacloprid, Herbicides, Plant Growth Regulators, Chlorpyrifos, Acaricide.
Who are the key members and board of directors at Aristo Bio-Tech And Lifescience?
Executive Team (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ketankumar Joshi ![]() | CFO | 10-Sep-2018 | Current |
Chinmay Chokshi | Company Secretary | Current | |
Narendra Barhat ![]() | Managing Director | 17-Mar-2005 | Current |
Board Members (5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rashmi Otavani ![]() | Director | 20-Mar-2022 | Current |
Ketankumar Joshi ![]() | Whole-Time Director and Cfo | 27-Aug-2018 | Current |
Kusum Barhat ![]() | Director | 17-Mar-2005 | Current |
Raghavender Mateti ![]() | Director | 10-Sep-2018 | Current |
Laxman Rathore ![]() | Director | 10-Sep-2018 | Current |
Financial Performance of Aristo Bio-Tech And Lifescience.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Aristo Bio-Tech And Lifescience?
Unlock access to Aristo Bio-Tech And Lifescience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Charges (Loans)
₹57.60 Cr
₹9.61 Cr
Charges Breakdown by Lending Institutions
- Others : 57.60 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
20 Sep 2022 | Others | ₹1.36 Cr | Open |
24 Nov 2021 | Others | ₹3.18 Cr | Open |
02 Dec 2020 | Others | ₹1.73 Cr | Open |
11 Jan 2007 | Others | ₹25.67 Cr | Open |
11 Jan 2007 | Others | ₹25.67 Cr | Open |
How Many Employees Work at Aristo Bio-Tech And Lifescience?
Unlock and access historical data on people associated with Aristo Bio-Tech And Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Aristo Bio-Tech And Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aristo Bio-Tech And Lifescience's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.